Certara Products - Simcyp Archives | Certara

On-Demand Webinar

充分发挥 PBPK 模型的全部潜力以加速药物研发

Explore how Novartis applies PBPK modeling in drug development using Simcyp to support regulatory decisions,…

Certara2026 年 3 月 20 日

博客

What are Common Bioequivalence Study Mistakes?

Learn about the most common bioequivalence study mistakes drug developers make and the differences between…

Certara2026 年 3 月 20 日

Blog

ICH M15 Guideline: What the Finalized Guideline Means for Model-Informed Drug Development

With the release of the draft ICH M15 guidance, MIDD is no longer optional -…

Certara2026 年 3 月 18 日

Conference

Discovery & Development Europe 2026

Certara2026 年 3 月 13 日

Announcement

Certara Expands Simcyp® Simulator to Streamline Regulatory Submissions and Internal Efficiencies

Discover how the Simcyp Simulator’s PBPK models can streamlines drug development and reduces the number…

Certara2026 年 3 月 5 日

博客

什么是 Simcyp Discovery 及其如何支持药物发现？

Learn how Simcyp helps in drug discovery, supporting compound selection, first-in-human PK prediction, early DDI…

Certara2026 年 3 月 3 日

Press Release

Certara Simcyp® Simulator 成果成功替代慢性髓性白血病（CML）药物 asciminib 的 10 项人体试验

Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical…

Certara2026 年 3 月 3 日

Conference

Marbach DDI Workshop 2026

Certara2026 年 2 月 26 日

Webinar

Maximizing the Impact of Antibody–Drug Conjugates (ADCs): Model-Informed Labeling, Expansion, and Market Access

Danielle Pillsbury2026 年 2 月 23 日

Webinar

Optimal Dosing, Optimal Outcomes: Model-Based Approaches for Antibody–Drug Conjugates (ADCs)

Certara2026 年 2 月 23 日

© 2026 Certara. 保留所有权力。 | 法律 | 隐私政策

沪ICP备2022021526号

Powered by Translations.com GlobalLink Web Software